Physician profile
John Kelley
NPI 1821085085
$1,703.19
in general payments reported to CMS, 2019-2025
9 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $588 · 2021: $16.88 · 2022: $81.99 · 2023: $43.27 · 2024: $169 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,141.09 | 2019-2025 | |
| Smith+Nephew, INC. | $355.51 | 2019-2024 | Intellio Link Werewolf, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Integra Lifesciences Corporation | $73.25 | 2024 | Biodrestore, Medihoney, Biodfactor |
| Depuy Synthes Sales INC. | $40.66 | 2020-2023 | Monovisc, Peak, Orthovisc |
| Vericel Corporation | $35.29 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.82 | 2025 | |
| Bioventus LLC | $18.69 | 2019 | |
| Globus Medical, INC. | $16.88 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.